Non-small Cell Lungs Cancer Treatment Market Market Size, Growth Drivers and Analysis 2037
The Non-Small Cell Lung Cancer (NSCLC) treatment market is experiencing significant expansion, fueled by breakthroughs in immunotherapy and targeted treatments that are transforming cancer care worldwide. In 2024, the market was valued at USD 17.9 billion, and it is projected to reach USD 42.9 billion by the end of 2037, registering the market is projected to expand at a 9.8% CAGR between 2025 and 2037. This remarkable growth is primarily fueled by a rising global cancer burden, enhanced diagnostic capabilities, and expanding healthcare access in emerging markets.